Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

Overview
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...
Amines to Sulfonamides: The Hinsberg Test01:23

Amines to Sulfonamides: The Hinsberg Test

The Hinsberg test is a method to identify primary, secondary and tertiary amines, named after its pioneer, Oscar Hinsberg. Here, amines are treated with benzenesulfonyl chloride, also known as the Hinsberg reagent, in the presence of an excess of aqueous base, followed by acidification. Based on the nature of the amines, different changes are observed.
Generally, a primary amine reacts with the Hinsberg reagent to produce an N-substituted benzenesulfonamide. The electron-withdrawing sulfonyl...
Phase II Reactions: Sulfation and Conjugation with α-Amino Acids01:19

Phase II Reactions: Sulfation and Conjugation with α-Amino Acids

Sulfation and α-amino acid conjugation are two critical biotransformation reactions in drug metabolism. Sulfation, a phase II biotransformation reaction, involves adding a polar sulfate group to a drug, enhancing its water solubility and promoting excretion. This process can either co-occur with or occur independently of glucuronidation. Nonmicrosomal sulfotransferase enzymes catalyze the process. The reaction involves 3'-phosphoadenosine-5'-phosphosulfate or PAPS coenzyme activation, sulfur...
Allergic Drug Reactions01:27

Allergic Drug Reactions

Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing numerous...
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Severe prolonged sedation associated with coadministration of protease inhibitors and intravenous midazolam during bronchoscopy: a commentary.

Pharmacotherapy·2012
Same author

Clarifying metformin's role and risks in liver dysfunction.

Journal of the American Pharmacists Association : JAPhA·2010
Same author

The use of wireless laptop computers for computer-assisted learning in pharmacokinetics.

American journal of pharmaceutical education·2006
Same author

Likelihood and mechanisms of cross-allergenicity between sulfonamide antibiotics and other drugs containing a sulfonamide functional group.

Pharmacotherapy·2004

Related Experiment Video

Updated: Jul 14, 2026

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

Sulfonamide allergy and cross-reactivity.

Carolyn C Brackett1

  • 1The Ohio State University, 500 West 12th Avenue, Columbus, OH 43210, USA. brackett.2@osu.edu

Current Allergy and Asthma Reports
|May 17, 2007
PubMed
Summary

Sulfonamide antibiotic allergies are not typically linked to nonantibiotic sulfonamide drugs. Different structures on these drugs prevent cross-reactivity, clarifying drug hypersensitivity.

Area of Science:

  • Pharmacology
  • Immunology
  • Drug Safety

Background:

  • Cross-allergenicity between sulfonamide antibiotics and nonantibiotic sulfonamide drugs complicates treatment.
  • Previous research indicates no interaction between the sulfonamide group and immune responses.

Purpose of the Study:

  • To clarify the immunologic basis for hypersensitivity reactions to sulfonamide antibiotics.
  • To determine the likelihood of cross-reactivity between sulfonamide antibiotics and nonantibiotic sulfonamide-containing drugs.

Main Methods:

  • Review of existing immunologic investigations on sulfonamide hypersensitivity.
  • Analysis of the structural determinants of immunologic responses to sulfonamide antibiotics.

Main Results:

Related Experiment Videos

Last Updated: Jul 14, 2026

Basophil Activation Test for Allergy Diagnosis
07:22

Basophil Activation Test for Allergy Diagnosis

Published on: May 31, 2021

  • Type I hypersensitivity to sulfonamide antibiotics is linked to the N1 heterocyclic ring, absent in nonantibiotic sulfonamides.
  • Non-type I hypersensitivity reactions are often due to stereospecific reactive metabolites of sulfonamide antibiotics at the N4 amino nitrogen, a feature absent in nonantibiotic sulfonamides.
  • Cellular immune responses, while involved in dermatologic reactions, are stereospecific, making cross-reactivity unlikely.

Conclusions:

  • Cross-reactivity between sulfonamide antibiotics and nonantibiotic sulfonamides is highly unlikely due to distinct structural features.
  • Apparent cross-reactivity is more likely due to multiple independent drug hypersensitivities occurring concurrently.